Mobility

Chondroitin

Sulfated glycosaminoglycan used primarily to reduce pain and improve function in knee osteoarthritis, with mixed research support.

Chondroitin

Sulfated glycosaminoglycan used primarily to reduce pain and improve function in knee osteoarthritis, with mixed research support.

score

evidence

Caution

risk

Proven Benefits

01Reduces OA pain and stiffness

02Improves joint function

03May slow joint space narrowing

04May improve hand OA symptoms

05May reduce NSAID use

Chemical Forms

Recommended

Chondroitin sulfate

Avoid

Unspecified or low-purity chondroitin (often <90% purity)
Non-sulfate chondroitin forms (less studied than sulfate)

Expert Note

Most clinical trials use purified chondroitin sulfate, typically dosed at 800-1200 mg. Oral bioavailability is low (~10-15%) and varies widely between products. Low-quality supplements may contain much less active compound than labeled, which likely contributes to mixed trial results.

Protocol

Amount

800-1200 mg

Frequency

Once daily or split into two doses

When

With meals to improve absorption and reduce stomach upset.

Condition-Based Dosing

Symptomatic knee osteoarthritis

800-1200 mg daily for 12 weeks, then reassess; continue up to 6 months if clearly helping.— Most symptom benefits appear by 8-12 weeks; stop if there is no meaningful improvement.

Safety & Limits

Upper Safe Limit

2000 mg/day is the highest commonly studied dose; no official UL established.

Cycling

Safe for continuous use

Contraindications

Warfarin or other anticoagulants — increased bleeding risk

Seafood allergy (marine-sourced products) — verify source

Pregnancy or breastfeeding — insufficient safety data

Synergies

Glucosamine

Often paired in osteoarthritis formulas; the combination may modestly improve symptoms, but it is not clearly superior to chondroitin alone.

Avoid Combining With

✕Warfarin or other anticoagulants (may increase INR and bleeding risk)

Updated Invalid Date